Our Blog

Avacta Group PLC – AVCT – Rapid Antigen Test Detects SARS-CoV-2 Variants

Avacta Group plc (AIM: AVCT), the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, announces that the AffiDX® SARS-CoV-2 rapid antigen lateral flow test detects the dominant new variants of the coronavirus, known as the B117, or ‘Kent’, variant, and the D614G variant, as well as the original strain.

Read More

Inspired Energy PLC – INSE – Final Results

Inspired Energy (AIM: INSE), the leading consultant for energy procurement, utility cost optimisation and legislative compliance in the UK and Ireland, announces its consolidated, audited final results for the year ended 31 December 2019.

Read More

N4 Pharma PLC – Covid-19 Project Update

Further to the Company’s announcement on 16 April 2020, N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to provide an update on the progress of its Covid-19 proof of concept work for Nuvec®.

Read More

Zinc Media Group PLC – Trading and COVID-19 Update

Zinc Media Group plc (AIM: ZIN), the TV and multimedia content producer, is pleased to announce good progress on its transformation plan during the current Covid-19 pandemic with £2.5m of new business won since lockdown began, and a growing pipeline of proposals which can be produced under social distancing rules, across its TV labels.   

Read More

RISK WARNING